USD 7.07
(1.02%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 29.51 Million USD | -47.62% |
2022 | 56.34 Million USD | -22.9% |
2021 | 73.07 Million USD | 29.35% |
2020 | 56.49 Million USD | 5649799900.0% |
2019 | 1.00 USD | 0.0% |
2018 | - USD | -100.0% |
2017 | 1.00 USD | 0.0% |
2016 | 1.00 USD | 0.0% |
2015 | - USD | -100.0% |
2014 | 1.00 USD | 0.0% |
2013 | 1.00 USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | 36.99 Million USD | 6.01% |
2024 Q1 | 32.26 Million USD | 9.33% |
2024 Q2 | 34.89 Million USD | 8.14% |
2023 Q3 | 35.91 Million USD | 5.47% |
2023 Q4 | 29.51 Million USD | -17.83% |
2023 FY | 29.51 Million USD | -47.62% |
2023 Q1 | 45.8 Million USD | -18.71% |
2023 Q2 | 34.05 Million USD | -25.65% |
2022 Q2 | 60.26 Million USD | -14.71% |
2022 Q1 | 70.65 Million USD | -3.32% |
2022 Q4 | 56.34 Million USD | -5.06% |
2022 FY | 56.34 Million USD | -22.9% |
2022 Q3 | 59.34 Million USD | -1.52% |
2021 Q4 | 73.07 Million USD | 28.35% |
2021 Q2 | 56.99 Million USD | -2.23% |
2021 Q3 | 56.93 Million USD | -0.09% |
2021 FY | 73.07 Million USD | 29.35% |
2021 Q1 | 58.29 Million USD | 3.17% |
2020 Q4 | 56.49 Million USD | 387.98% |
2020 FY | 56.49 Million USD | 5649799900.0% |
2020 Q3 | 11.57 Million USD | 1157799900.0% |
2020 Q2 | 1.00 USD | 0.0% |
2020 Q1 | 1.00 USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q1 | 1.00 USD | 0.0% |
2019 Q2 | - USD | -100.0% |
2019 FY | 1.00 USD | 0.0% |
2019 Q4 | 1.00 USD | 0.0% |
2018 Q2 | - USD | -100.0% |
2018 Q3 | - USD | 0.0% |
2018 FY | - USD | -100.0% |
2018 Q4 | - USD | 0.0% |
2018 Q1 | 1.00 USD | 0.0% |
2017 Q2 | 1.00 USD | 0.0% |
2017 Q1 | 1.00 USD | 0.0% |
2017 FY | 1.00 USD | 0.0% |
2017 Q4 | 1.00 USD | 0.0% |
2017 Q3 | 1.00 USD | 0.0% |
2016 Q1 | 1.00 USD | 0.0% |
2016 Q2 | - USD | -100.0% |
2016 FY | 1.00 USD | 0.0% |
2016 Q4 | 1.00 USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | -100.0% |
2015 FY | - USD | -100.0% |
2014 Q4 | 1.00 USD | 0.0% |
2014 FY | 1.00 USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 FY | 1.00 USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Phreesia, Inc. | - USD | -Infinity% |
Accuray Incorporated | 138.32 Million USD | 78.664% |
Align Technology, Inc. | 296.9 Million USD | 90.06% |
Elevance Health Inc. | -46.33 Billion USD | 100.064% |
AxoGen, Inc. | 23.02 Million USD | -28.206% |
Boston Scientific Corporation | 2.48 Billion USD | 98.812% |
CVS Health Corporation | 18.02 Billion USD | 99.836% |
Cardinal Health, Inc. | 14.95 Billion USD | 99.803% |
Centene Corporation | - USD | -Infinity% |
DaVita Inc. | 143.1 Million USD | 79.377% |
HCA Healthcare, Inc. | 2.02 Billion USD | 98.54% |
Hologic, Inc. | 679.8 Million USD | 95.659% |
Humana Inc. | - USD | -Infinity% |
IDEXX Laboratories, Inc. | 380.28 Million USD | 92.239% |
Laboratory Corporation of America Holdings | 474.6 Million USD | 93.782% |
Masimo Corporation | 545 Million USD | 94.585% |
McKesson Corporation | 21.13 Billion USD | 99.86% |
Patterson Companies, Inc. | 782.89 Million USD | 96.23% |
Quest Diagnostics Incorporated | 190 Million USD | 84.467% |
ResMed Inc. | 822.25 Million USD | 96.411% |
Henry Schein, Inc. | 1.81 Billion USD | 98.374% |
Universal Health Services, Inc. | 216.98 Million USD | 86.399% |
Veeva Systems Inc. | - USD | -Infinity% |
Baxter International Inc. | 2.82 Billion USD | 98.955% |
Becton, Dickinson and Company | 3.27 Billion USD | 99.098% |
Intuitive Surgical, Inc. | 1.22 Billion USD | 97.582% |
Danaher Corporation | 2.59 Billion USD | 98.862% |
Stryker Corporation | 4.84 Billion USD | 99.391% |
Medtronic plc | 5.21 Billion USD | 99.434% |